Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Mutant Genes In High-Risk Childhood Leukemias Identified
A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death. The finding suggests specific drugs that could treat this high-risk leukemia subtype in children, particularly because such drugs are already in clinical trials for similar blood diseases in adults.

Expert Statement Issued About Lantus(R) Following Recent Publications In Diabetologia
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced the release of an Expert Statement by a multidisciplinary board of renowned international experts following an in-depth assessment of the recent publications of registry analyses with Lantus(R) (insulin glargine [rDNA] injection) in Diabetologia. This board of international specialists in the field of endocrinology, oncology and epidemiology came to the conclusion, that all four manuscripts have significant methodological limitations and shortcomings, and that they provide inconsistent and inconclusive results regarding a potential link between insulin glargine use and an increased risk of cancer.
News of the day
Local Schools And Families To Meet Plague Doctor
In June, the Royal College of Physicians will be holding a series of workshops with local schools and families exploring The Great Plague of 1665 and the involvement of the Royal College of Physicians.
Mental Health

UPMC Surgeon Performs 2,000th Prostate Cancer Surgery In Pittsburgh

Joel B. Nelson, M.D., chairman of the University of Pittsburgh Medical Center"s (UPMC) Department of Urology, performed his 2,000th radical prostatectomy at UPMC Shadyside, a milestone achieved by only a handful of surgeons worldwide. Radical prostatectomy, or removal of the entire prostate gland, is the most common treatment for patients with localized prostate cancer. Studies show that recovery from prostate cancer is significantly associated with a surgeon"s lifetime experience performing this operation. "Research supports common sense: Patients undergoing surgery by more experienced surgeons will have a better chance of being cured of their cancer," said Dr. Nelson. "With a practice entirely focused on men with localized prostate cancer has come a wealth of experience, leading to continuous refinement in surgical technique and improved outcomes. For most patients, a one-day hospital stay is routine." Surgeons in the Department of Urology also offer robotic-assisted laparoscopic radical prostatectomy. Initiated in 2004, UPMC"s robotic prostatectomy program was the first in the region, and surgeons in the department recently performed their 500th robotic procedure. Dr. Nelson joined UPMC in 1999 to lead the newly formed Department of Urology. He is one of the country"s leading surgeons performing nerve-sparing radical prostatectomy, an operation in which a cancerous prostate gland is removed but the nerves controlling erections are not. More than 90 percent of his operations are nerve-sparing, which is a significantly higher percentage than the national average. After earning his medical degree from Northwestern University, Dr. Nelson completed surgical and urological residencies at the McGraw Medical Center of Northwestern University and a fellowship at the Johns Hopkins Brady Urological Institute. He also served as assistant professor of urology and oncology at the Johns Hopkins University School of Medicine and director of urologic oncology at the Johns Hopkins Bayview Medical Center. University of Pittsburgh Medical Center

Breast Augmentations commented:

thanks for sharing it with people the tips for cancer surgery. I really appreciate with what you have written

19.04.2012


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009